PART OF LETTER FROM FIFA TO ZIFA We have been notified by WADA-accredited Doping Control Laboratory in Bloemfontein that the analysis of sample 3408632 taken during the 2014 Fifa World Cup Brazil Qualifying Match Zimbabwe versus Egypt on 9 June 2013 revealed an adverse analytical finding (see enclosed laboratory report). The sample 3408632 has been allocated to the player Chafa Devon Taitamba. The prohibited substance found in the player’s sample is prednisolone and falls in the Class S9 (glucocorticosteroids) of the Prohibited List Applicable regulation. We would like to draw the player’s and Zimbabwe Football Association Limited’s attention to the Fifa Anti-Doping Regulations (hereinafter ADR) that apply in the proceedings in question and inform that the player appears to have violated Article 6 of the Fifa Anti-Doping Regulations and has the right to request a copy of the laboratory documentation package. In accordance with Article 61 par.1 of the ADR, the player may request the analysis of the ‘B’ sample within 48 hours of receipt of this notification. All related laboratory costs of this analysis would have to be borne by player, unless the ‘B’ sample fails to confirm the ‘A’ sample. The player and/or a representative may be present at the opening of the ‘B’ sample. If the players does not request the analysis of the ‘B’ sample within the mentioned deadline, we will deem that the player waived his right and the results of the analysis of the ‘A’ sample will be deemed confirmed. We ask the Zimbabwe Football association to immediately forward this information to the player, Chafa Devon Taitamba, and to ensure that the method of communication may be traced (fax confirmation, registered mail, signature of player as confirmation of receipt etc) and to provide Fifa immediately with the proof of receipt. From FIFA Chief Medical Officer Jiri Dvorak, and Anti-Doping Manager Tanja Vogel. Cc: Herald
Posted on: Wed, 28 Aug 2013 04:48:08 +0000
Trending Topics
Recently Viewed Topics
© 2015